The valuation of commercial opportunities has significant uncertainty. Our approach to evaluating commercial opportunities is meticulous and thorough. We provide our clients with comprehensive guidance throughout the entire process, utilizing a diverse array of qualitative and quantitative research techniques. Our team answers fundamental questions, such as identifying unmet needs in the marketplace, determining the value of a potential new product, assessing the size of the total addressable market opportunity, analyzing the current and future competitive landscape, and predicting the likely demand for the product.

Forecasting

Rosenblatt Life Science Consultants provides advanced predictive analytics and forecasts that help quantify the future performance of products and markets.

CLIENT SUCCESS STORIES

Our forecasting experts strategically assess opportunities for markets, brands & business units. We accurately forecast unit sales and/or patient volume for brands and markets. We provide transaction support for both sell & buy-side transactions, characterizing and quantifying risk under conditions of uncertainty.

Our Approaches: Epidemiology-based modeling is typically used for new markets or to forecast new indications, to better understand the patient and utilization cascade. Patient flow models apply simulation techniques that follow patient cohorts over time & under changing circumstances. Our unique demand-based methods and models are used for well established markets or brands, focusing on statistical time series methods & insightful analog selection.

Market
Research

Rosenblatt Life Science Consultants provides primary market research that creates an in-depth understanding of the drivers and trends that characterize commercial opportunity for life sciences therapeutics, diagnostics and devices.

CLIENT SUCCESS STORIES

We provide deep insights to our clients applying both qualitative & quantitative research techniques with physicians, payers & patients.
Qualitative Research: We conduct in-depth interviews (IDIs), focus groups and advisory boards for research that requires deep content findings with smaller sample sizes. We exclusively use our own in-house moderators. We are subject matter experts using internally developed discussion guides adding our informed and nuanced probes providing enhanced depth of insight. We have deep expertise across the scientific, clinical and commercial aspects of multiple therapy areas, and are equipped to have “peer-to-peer” discussions with other technical professionals

Quantitative Research: We provide global quantitative research services Using larger
sample sizes we employ sophisticated statistical procedures (e.g. conjoint analysis and discrete choice modeling) to determine how product/service/portfolio attributes are valued and trade-off decisions are made. Our marketing scientist professionals have extensive expertise in commercial analysis and strategy.
Typical Use Cases: Therapeutic landscape analysis; quantifying market and product opportunity to support in/out licensing and acquisition; patient journey studies; ATU and tracking studies; physician & patient segmentation; brand performance tracking; pricing and market assess analytics.

Pricing &
Market Access

Our pricing & market access consultants help clients across all
therapeutic areas navigate the payer environment to better
understand optimal access at appropriate prices.

CLIENT SUCCESS STORIES

Our experts characterize the essential & actionable payer landscape issues to determine product pricing & market access strategy & tactics. We utilize various methodologies including conjoint and discrete choice analysis; Van Westendorp to determine price sensitivity and Gabor-Granger to assess a customer’s likelihood to purchase.

We understand the nuances in both the private and public payer environments. We are very familiar with the many initiatives installed to help curtail some of the costs associated with specialty product markets, including site of care strategies that direct care to the least costly option, dosing optimization to eliminate waste associated with partial vials, education and emphasis on palliative care, and quantity limits and more frequent reauthorizations.

Valuation &
Financial Advisory

Rosenblatt Life Science Consultants financial valuation & advisory services supports investors & client companies engaged in capital decisions providing independent and objective opinions

CLIENT SUCCESS STORIES

Combining deep technical expertise in life sciences, diagnostics, and devices markets with proven financial knowledge, we deliver buy-side and sell-side support, internal strategic decision-support, and independent opinion services to help our clients make informed decisions. Our valuations support access to capital markets, tax reporting, and financial reporting.

Bloomberg: Rosenblatt Life Science Consultants exclusively provides the life sciences market and epidemiology models for the Bloomberg Terminal. Our work is an important research tool for stakeholders who require current landscape data and forward-looking analyses of high-value therapeutic areas.

Not all opportunities are of equal size and importance.

Opportunity Assessment

Forecasting

MarketResearch

Pricing &Market Access

Valuation &Financial Advisory

Market
Research

Pricing &
Market Access

Valuation &
Financial Advisory